Significant variations in first-line mantle cell lymphoma care—an Australasian Lymphoma and Related Diseases Registry study

Authors:
Open Access
Publisher website
Google Scholar
Abstract
Mantle cell lymphoma (MCL) is a rare subtype of non-Hodgkin lymphoma, comprising <5% of all lymphoma diagnoses [1]. Despite increasingly recognized biological and clinical heterogeneity, first-line...
Funding Information
  • AbbVie Canada
  • Antengene
  • AstraZeneca
  • BeiGene
  • Bristol Myers Squibb
  • Celgene
  • Gilead Sciences
  • Johnson and Johnson
  • Novartis Portugal
  • Roche
  • Sandoz
  • Specialised Therapeutics
  • Takeda Pharmaceuticals U.S.A.

This publication has 44 references indexed in Scilit: